Exhibitor Spotlight: Solventum
3M Health Care is now Solventum. Solventum enables better, smarter, safer healthcare to improve lives.
3M Health Care is now Solventum. Solventum enables better, smarter, safer healthcare to improve lives.
For over 20 years, Moog Medical has been designing proven, reliable, and easy-to-use infusion pumps (CURLIN) and enteral feeding pumps (Infinity) that provide precise and steady fluid delivery.
McKesson Medical‑Surgical delivers a comprehensive suite of infusion products and services designed to empower infusion pharmacies across the U.S. With solutions that strengthen revenue performance and elevate patient care, we serve as a true partner in operational excellence.
Managed Healthcare Associates (MHA) is a national group purchasing organization (GPO) serving specialty and alternate site providers of every size, including home infusion pharmacies.
Eitan Medical develops advanced infusion therapy solutions designed specifically for home and alternate site care settings. Our portfolio includes ambulatory infusion pumps such as the Sapphire and Avoset platforms, along with administration sets, accessories, and a digital health platform, Eitan Insights.
Accelerate Pharmacy Solutions (APS), part of Cencora, helps health systems protect and grow their infusion program by building or optimizing diversified sites of care, including home infusion, ambulatory infusion suites (AIS), and ambulatory infusion centers (AIC).
WeInfuse is the premier technology and consulting provider for infusion therapy and medication delivery in the U.S. The WeInfuse software platform powers the end-to-end workflow for infusion centers and home infusion and specialty pharmacies nationwide.
CorMedix Therapeutics is a biopharmaceutical company that develops and delivers breakthrough therapies for the prevention and treatment of life-threatening illnesses, ensuring patients have access to our innovative products while building an organization that values integrity, collaboration, and performance.
Trella Health provides market insights, sales productivity tools, and actionable insights that help home and alternate site infusion providers grow smarter and compete more effectively.
Since 1994, IMS has served as a trusted national distributor exclusively focused on the home and alternate site infusion industry. We take a solution-oriented approach to all of our offerings, providing flexible rental, purchase, and disposable options across our infusion, respiratory, enteral feeding, and cleanroom categories.
Tuesday morning at NHIA 2026 featured a breakfast symposium covering the complexities of Secondary Immunodeficiencies and our innovative 30-30-30 sessions that cover a central topic from 3 angles with unique perspectives. Our closing Keynote Arel Moodie shared the principles of powerful research called Adult Development Theory to help explain why people act and make the decisions they do and how to leverage different modes of being to best accomplish the task at hand or lead your teams to achieve their goals.
Monday morning kicked off with a high-octane networking breakfast before the General Session which featured a panel of legislative and regulatory experts covering the latest policy developments affecting the home infusion industry. We were also proud to honor Melissa Leone, RN, BSN, FNHIA as this year’s Gene Graves Lifetime Achievement Award Recipient for her 35+ year career focused on developing operational practices that enabled consistently safe care for patients while mentoring and developing the clinical leaders of the future.
NHIA 2026 convened the largest gathering dedicated to the home and alternate site infusion industry in Denver, Colorado, featuring the event’s most extensive Expo ever with more than 150 product and service suppliers supporting the industry, including 40 first-time exhibitors. The conference continued to see an increase in individuals investing to attend the conference and more than 1,700 industry professionals attended the 5-day event.
Specialized therapy administration in the home is becoming increasingly complex. As sites of care continue shifting toward the home, complex therapies are following.